• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜粘连评估作为支气管内瓣膜治疗后气胸的预测指标。

Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment.

机构信息

Department of Respiratory Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.

出版信息

Respiration. 2017;94(2):224-231. doi: 10.1159/000477258. Epub 2017 Jun 22.

DOI:10.1159/000477258
PMID:28637047
Abstract

BACKGROUND

Pneumothorax after bronchoscopic lung volume reduction using one-way endobronchial valves (EBVs) in patients with advanced emphysema occurs in approximately 20% of patients. It is not well known which factors predict the development of pneumothorax.

OBJECTIVE

To assess whether pleural adhesions on pretreatment high-resolution computed tomography (HRCT) scans are associated with pneumothorax occurrence after EBV treatment.

METHODS

HRCT scan analyses were performed on all patients who received EBV treatment in a randomized controlled trial. Three blinded readers scored adhesions by number and by measuring the longest axis of each pleural adhesion in the treated lung. The Pleural Adhesion Score (PAS) was calculated by adding 1 point for each small pleural lesion (<1 mm), 5 points for each medium-sized lesion (1-5 mm), and 10 points for each large lesion (>5 mm).

RESULTS

The HRCT scans of 64 treated patients were assessed, of whom 14 developed pneumothorax. Patients who developed pneumothorax had a higher median number of pleural adhesions, 2.7 (IQR 1.9-4) compared to 1.7 (1-2.7) adhesions in the group without pneumothorax (p < 0.01). The PAS in the group with pneumothorax was higher compared to that in the group without: 14.3 (12.4-24.1) versus 6.7 (3.7-11.2) (p < 0.01). A threshold PAS of ≥12 was associated with a higher risk of pneumothorax (OR 13.0, 95% CI 3.1-54.9). A score <12 did not rule out the occurrence of pneumothorax.

CONCLUSION

A higher number of pleural adhesions on HRCT with a subsequent higher PAS in the treated lung is associated with a higher occurrence of pneumothorax after EBV treatment.

摘要

背景

在接受单向支气管内瓣膜(EBV)治疗的晚期肺气肿患者中,约 20%的患者会出现气胸。目前尚不清楚哪些因素可预测气胸的发生。

目的

评估治疗前高分辨率计算机断层扫描(HRCT)上的胸膜粘连是否与 EBV 治疗后气胸的发生有关。

方法

对所有接受 EBV 治疗的患者进行 HRCT 扫描分析。三位盲法读者通过数量和测量治疗肺中每个胸膜粘连的最长轴对粘连进行评分。胸膜粘连评分(PAS)通过对每个小胸膜病变(<1mm)加 1 分,每个中等大小病变(1-5mm)加 5 分,每个大病变(>5mm)加 10 分来计算。

结果

共评估了 64 例接受治疗的患者的 HRCT 扫描结果,其中 14 例发生气胸。发生气胸的患者胸膜粘连中位数更高,为 2.7(IQR 1.9-4),而无气胸组为 1.7(1-2.7)(p<0.01)。气胸组的 PAS 高于无气胸组:14.3(12.4-24.1)比 6.7(3.7-11.2)(p<0.01)。PAS≥12 与气胸风险增加相关(OR 13.0,95%CI 3.1-54.9)。评分<12 并不能排除气胸的发生。

结论

治疗肺中 HRCT 上的胸膜粘连数量较多,随后的 PAS 较高与 EBV 治疗后气胸的发生频率较高相关。

相似文献

1
Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment.胸膜粘连评估作为支气管内瓣膜治疗后气胸的预测指标。
Respiration. 2017;94(2):224-231. doi: 10.1159/000477258. Epub 2017 Jun 22.
2
Endobronchial Valves Therapy for Advanced Emphysema: A Meta-Analysis of Randomized Trials.支气管内瓣膜治疗晚期肺气肿:随机试验的荟萃分析
J Bronchology Interv Pulmonol. 2019 Apr;26(2):81-89. doi: 10.1097/LBR.0000000000000527.
3
Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.经支气管镜肺减容术联合支气管内活瓣治疗存在不均一性肺气肿且肺裂完整的患者(BeLieVeR-HIFi 研究):一项随机对照试验。
Lancet. 2015 Sep 12;386(9998):1066-73. doi: 10.1016/S0140-6736(15)60001-0. Epub 2015 Jun 23.
4
Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction.用于内镜下肺减容的支气管内瓣膜:内镜下肺减容专家小组的最佳实践建议
Respiration. 2017;93(2):138-150. doi: 10.1159/000453588. Epub 2016 Dec 20.
5
First in Human Experience of the Performance of the New 5.5-LP Size Zephyr Endobronchial Valve.新型 5.5-LP 尺寸 Zephyr 支气管内瓣膜的人体首秀。
Respiration. 2020;99(1):50-55. doi: 10.1159/000504182. Epub 2019 Nov 26.
6
Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.支气管内瓣膜治疗均匀性肺气肿患者。IMPACT 研究结果。
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1073-1082. doi: 10.1164/rccm.201607-1383OC.
7
Endobronchial valves: 1st Multicenter retrospective study on the 2-step approach.支气管内瓣膜:2 步治疗法的首个多中心回顾性研究。
Respir Med Res. 2023 Jun;83:100957. doi: 10.1016/j.resmer.2022.100957. Epub 2022 Oct 1.
8
Endoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema and Very Low FEV1.在重度肺气肿且第一秒用力呼气容积(FEV1)极低的患者中使用支气管内瓣膜进行内镜下肺减容术
Respiration. 2016;92(4):258-265. doi: 10.1159/000448761. Epub 2016 Sep 8.
9
Non-Answered Questions in Patients with Endobronchial Valve Placement for Lung Volume Reduction.肺减容术后行支气管内瓣膜置入患者的未回答问题。
Respiration. 2018;95(4):269-272. doi: 10.1159/000484252. Epub 2018 Feb 14.
10
Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema.重度肺气肿患者内镜下瓣膜治疗后气胸的预测因素。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 1;11:1767-73. doi: 10.2147/COPD.S106439. eCollection 2016.

引用本文的文献

1
Lessons Learned: Risk Factors and Clinical Impact of Severe Pneumothorax After Endoscopic Lung Volume Reduction With Endobronchial Valves.经验教训:经支气管内瓣膜进行内镜下肺减容术后严重气胸的危险因素及临床影响
Chest. 2025 Apr;167(4):1012-1023. doi: 10.1016/j.chest.2024.10.045. Epub 2024 Nov 8.
2
Lung-Mimetic Hydrofoam Sealant to Treat Pulmonary Air Leak.肺仿生水凝胶泡沫密封剂治疗肺漏气。
Adv Healthc Mater. 2024 May;13(13):e2303026. doi: 10.1002/adhm.202303026. Epub 2024 Feb 14.
3
Predictors of reoperation after lung volume reduction surgery.
肺减容术后再次手术的预测因素。
Surg Endosc. 2024 Feb;38(2):679-687. doi: 10.1007/s00464-023-10559-z. Epub 2023 Nov 28.
4
Implementation of Bronchoscopic Lung Volume Reduction Using One-Way Endobronchial Valves: A Retrospective Single-Centre Cohort Study.经单向支气管内活瓣置入术实现支气管镜肺减容:一项回顾性单中心队列研究。
Respiration. 2022;101(5):476-484. doi: 10.1159/000520885. Epub 2021 Dec 22.
5
Dual-Energy Computed Tomography Compared to Lung Perfusion Scintigraphy to Assess Pulmonary Perfusion in Patients Screened for Endoscopic Lung Volume Reduction.双能 CT 与肺灌注闪烁显像对比评估接受内镜肺减容术筛选患者的肺灌注。
Respiration. 2021;100(12):1186-1195. doi: 10.1159/000517598. Epub 2021 Aug 10.
6
Expert Statement: Pneumothorax Associated with One-Way Valve Therapy for Emphysema: 2020 Update.专家声明:与肺气肿单向活瓣治疗相关的气胸:2020 更新。
Respiration. 2021;100(10):969-978. doi: 10.1159/000516326. Epub 2021 Jun 1.
7
The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion.胸膜内桥连是局限性胸膜粘连原因不明的原因之一。
Int J Gen Med. 2021 Apr 20;14:1429-1435. doi: 10.2147/IJGM.S299606. eCollection 2021.
8
Endobronchial Valves for the Treatment of Advanced Emphysema.支气管内瓣膜治疗晚期肺气肿。
Chest. 2021 May;159(5):1833-1842. doi: 10.1016/j.chest.2020.12.007. Epub 2020 Dec 17.
9
Endobronchial valves for severe emphysema.支气管内阀治疗严重肺气肿。
Eur Respir Rev. 2019 Apr 17;28(152). doi: 10.1183/16000617.0121-2018. Print 2019 Jun 30.
10
Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice.肺气肿型慢性阻塞性肺疾病(COPD)患者的瓣膜治疗:从随机试验到临床实践中的患者选择
J Thorac Dis. 2018 Aug;10(Suppl 23):S2780-S2796. doi: 10.21037/jtd.2018.08.86.